Loading...

Genetic polymorphisms and gene-dosage effect in ovarian cancer risk and response to paclitaxel/cisplatin chemotherapy

BACKGROUND: Ovarian malignancies are often diagnosed in advanced stage and at the same time resistance to treatment, both intrinsic and developed during treatment, is sometimes observed. These facts underscore the need for new markers of ovarian cancer risk, as well as markers of treatment effective...

Full description

Saved in:
Bibliographic Details
Published in:J Exp Clin Cancer Res
Main Authors: Tecza, Karolina, Pamula-Pilat, Jolanta, Kolosza, Zofia, Radlak, Natalia, Grzybowska, Ewa
Format: Artigo
Language:Inglês
Published: BioMed Central 2015
Subjects:
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC4320471/
https://ncbi.nlm.nih.gov/pubmed/25591549
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13046-015-0124-y
Tags: Add Tag
No Tags, Be the first to tag this record!